The gamma-Gompertz multiplicative frailty model is the most common parametric model applied to human mortality data at adult and old ages. The resulting life expectancy has been calculated so far only numerically.
OBJECTIVE
Properties of the gamma-Gompertz distribution have not been thoroughly studied. The focus of the paper is to shed light onto its first moment or, demographically speaking, characterize life expectancy resulting from a gamma-Gompertz force of mortality. The paper provides an exact formula for gamma-Gompertz life expectancy at birth and a simpler high-accuracy approximation that can be used in practice for computational convenience. In addition, the article compares actual (life-table) to model-based (gamma-Gompertz) life expectancy to assess on aggregate how many years of life expectancy are not captured (or overestimated) by the gamma-Gompertz mortality mechanism.
COMMENTS A closed-form expression for gamma-Gomeprtz life expectancy at birth contains a special (the hypergeometric) function. It aids assessing the impact of gamma-Gompertz parameters on life expectancy values. The paper shows that a high-accuracy approximation can be constructed by assuming an integer value for the shape parameter of the gamma distribution. A historical comparison between model-based and actual life expectancy for Swedish females reveals a gap that is decreasing to around 2 years from 1950 onwards.
Looking at remaining life expectancies at ages 30 and 50, we see this gap almost disappearing.
Relationship
Suppose in a population individuals die according to a force of mortality
where Z is a random variable, called frailty (Vaupel, Manton, and Stallard 1979) , which accounts for unobserved heterogeneity across individuals, and µ(x) is the baseline force of mortality. Model (1) is called a multiplicative (frailty) model. Assume µ(x) follows the Gompertz law
and frailty is gamma-distributed, i.e. Z ∼ Γ(k, λ) has a probability density function
Then life expectancy at birth e 0 can be expressed as
where 2 F 1 (α, β; γ; z) is the Gaussian hypergeometric function Abramowitz and Stegun 1965, 15.1.1, p.556) . If the shape parameter k of the gamma distribution is an integer, then
and, moreover, (4) serves as a high-accuracy approximation of (2) even when k is not integer. As a result, gamma-Gompertz life expectancy can be calculated by using (4).
Proof of the Relationship
Life expectancy is the integrated survivorship of the population across all ages
In a gamma-Gompertz multiplicative model S(x) = 1 + a bλ e bx − 1 −k and thus
(see Abramowitz and Stegun 1965, 15.3 .1, p.558), (6) reduces to (2). Relationship (4) is obtained by integrating k times the right-hand side of (5) by parts.
Q.E.D.
History and Related Results
The gamma-Gompertz multiplicative frailty model (1) has been introduced in demography by Vaupel, Manton, and Stallard (1979) . While capturing the observed bending of human mortality rates at older ages (see Beard 1959) , it also takes into account unobserved heterogeneity. Relationship (2) describes, on the one hand, the first moment of the mixture gamma-Gompertz distribution and, from a demographic point of view, the expected lifetime duration under the gamma-Gompertz assumption. The fact that gamma-Gompertz life expectancy is proportional to a hypergeometric function with a z-argument close to 1 (for human populations a ∝ 10 −6 , b ≈ 0.14, and k = λ > 1) sheds light on the dynamics of e 0 with respect to model parameters. As γ − α − β = 0 for the hypergeometric function 2 F 1 in (2), life expectancy is an increasing function of z for z → 1− and lim z→1 2 F 1 (α, β; γ; z) = +∞ (see Abramowitz and Stegun 1965, p.556, 15.1.1(c) ). This implies that e 0 increases when a declines keeping all other parameters fixed, which is intuitively justified as a denotes the starting level of mortality. A little counterintutive is the finding that life expectancy increases as the rate of aging b = d ln µ(x)/dx increases (see Figure 1) . The gamma parameters k and λ, often assumed to be equal to one another, so that µ(x) denotes the force of mortality of the "standard" individual (with frailty Z = 1), have one and the same impact on life expectancy -the higher k, λ, the higher e 0 . Note that when baseline mortality µ(x) in (1) is Gompertz-Makeham, i.e.
µ(x) = ae bx + c , and, consequently,
the corresponding life-expectancy integral
dx cannot be solved analytically, even for integer values of k.
As already pointed out, for human populations we have 1 − a/bλ ≈ 1, which leads to further simplification of (4):
Note that when k = λ (often assumed, see Vaupel, Manton, and Stallard (1979) ), the right-hand side of (7) contains the difference between the partial sum of the harmonic series and the natural logarithm:
The limit of the latter when k → ∞ is the Euler-Mascheroni constant γ * ≈ 0.577. Note that k → ∞ corresponds to the case when the Gompertz model for a gammaheterogeneous population tends to the Gompertz model for a homogeneous population. As a result, life expectancy at birth for a homogeneous population experiencing a Gompertz force of mortality could be approximated by
An expression for remaining life expectancy e x at age x in terms of a hypergeometric function can also be derived. Consider the indefinite integral in the right-hand side of (5):
A y = e −bx substitution will result in
Taking into account (see Lebedev 1965 , p.258)
and 2 F 1 (α, β; γ; z) = 2 F 1 (β, α; γ; z) , we have 
Applications
Relationship (2) and its approximation (4) can be used to measure the difference between actual (calculated by lifetable methods) and model-predicted (based on the estimation of gamma-Gompertz parameters) life expectancy at birth. This difference quantifies the cumulative excess infant and adult mortality. Figure 2 illustrates this gap for Swedish females from 1891 to 2010. As infant mortality improves over time, the difference decreases from 1950 onwards to an almost constant value of about 2 years. If we use expression (10) or its approximation (for integer k) analogous to (4), we can see that the gap between actual and fitted gamma-Gompertz remaining life expectancy decreases over age x (see Figure 3) . This illustrates on aggregate the phenomenon that most deaths which are not captured by the gamma-Gompertz model, occur from infant to young adult ages.
Empirically, it does not make a significant difference whether life expectancy is calculated in terms of the hypergeometric function (2) or by approximation (4). I use the data for Swedish females (HMD 2012) to estimate parameters a, b, and k (assuming k = λ) by miximizing a Poisson likelihood of the respective death counts. I start at age 70, assuming the baseline force of mortality onwards to be purely Gompertz, and calculate the initial mortality level by multiplying the estimatedâ by exp{(initial age − 70)b}, whereb is the maximum-likelihood estimate of b. Table 1 shows observed and fitted gamma-Gompertz life expectancies at birth and at age 30 for Swedish females in several specified years, illustrating how close these values are, regardless of the proximity ofk to its closest integer [k] . This implies that one can use (4) instead of (2) without losing much precision.
Approximations (7) and (8) are not very accurate as small deviations a/bk (k = λ) from 1 can lead to substantial deviations from (4) and, thus, from (2). They can be used, though, to assess the impact of model parameters on the values of life expectancy at birth.
Conclusion
Life expectancy in a gamma-Gompertz multiplicative model can be expressed analytically in terms of a special function (the hypergeometric series), which provides insight on life expectancy dynamics with respect to model parameters. In practice, one can use highaccuracy approximation (4) instead of (2) to calculate model-based e 0 for fitted parameter values. The difference between the latter and actual (life-table) life expectancy at birth or any age x could tell how many years of actual life expectancy are potentially due to causes not captured by the gamma-Gompertz frailty model. 
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